X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-20 | PODD | Insulet Corp | McEvoy Ashley | Pres, CEO | P - Purchase | $239.35 | +4,300 | 13,920 | +45% | +$1,029,205 | ||||||
2026-02-20 | CVRX | Cvrx, Inc. | Jain Mudit K. | Dir | P - Purchase | $6.36 | +46,800 | 985,833 | +5% | +$297,592 | ||||||
| M | 2026-02-19 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.47 | +150,000 | 51,558,909 | 0% | +$219,755 | |||||
2026-02-19 | GF | New Germany Fund Inc | Saba Capital Management, L.P. | 10% | P - Purchase | $12.20 | +17,044 | 2,512,366 | +1% | +$207,937 | ||||||
2026-02-19 | PMN | Promis Neurosciences Inc. | Kaplan Johanne | Chief Development Officer | P - Purchase | $15.35 | +1,629 | 3,941 | +70% | +$25,005 | ||||||
2026-02-20 | FINS | Angel Oak Financial Strategies Income Term Trust | Cohen IRA P | Dir | P - Purchase | $13.17 | +379 | 379 | New | +$4,991 | ||||||
2026-02-20 | RCG | Renn Fund, Inc. | Stahl Murray | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.84 | +1,134 | 1,041,508 | 0% | +$3,221 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |